← All companies

IMVT

Immunovant, Inc.

IMVT Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$38.51

-0.97 -2.46%

Key statistics

from XBRL data in SEC filings

Market cap

$7.91B

Revenue (TTM)

—

Net income (TTM)

-$506M

EPS (TTM)

$-2.77

P/E ratio

—

Dividend yield

—

Free cash flow

-$407M

Cash

$902M

Total assets

$957M

Gross margin

—

52-week range

$14.32 – $41.23

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-K Fiscal year ended 2026-03-31 May 20, 2026 8-K Results of operations (earnings release) May 20, 2026 10-Q Quarter ended 2025-12-31 Feb 6, 2026 8-K Results of operations (earnings release) Feb 6, 2026 8-K Other events Dec 12, 2025 8-K Other events Dec 11, 2025 8-K Director or officer change Nov 21, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Regulation FD disclosure; Other events Sep 3, 2025 8-K Shareholder vote results Aug 28, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release) Aug 11, 2025 8-K Director or officer change Jul 29, 2025 10-K Fiscal year ended 2025-03-31 May 29, 2025 8-K Results of operations (earnings release) May 29, 2025 8-K Director or officer change; Regulation FD disclosure; Other events Apr 21, 2025 8-K Regulation FD disclosure; Other events Mar 19, 2025 10-Q Quarter ended 2024-12-31 Feb 6, 2025 8-K Results of operations (earnings release) Feb 6, 2025 8-K Other events Jan 24, 2025 8-K Regulation FD disclosure Jan 14, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release); Other events Nov 7, 2024 8-K Regulation FD disclosure; Other events Sep 9, 2024 8-K Shareholder vote results Aug 13, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 10-K Fiscal year ended 2024-03-31 May 29, 2024 8-K Results of operations (earnings release) May 29, 2024 10-Q Quarter ended 2023-12-31 Feb 12, 2024 8-K Results of operations (earnings release) Feb 12, 2024 8-K Regulation FD disclosure Jan 9, 2024 8-K Regulation FD disclosure; Other events Dec 20, 2023 8-K Regulation FD disclosure; Other events Nov 28, 2023 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release) Nov 9, 2023 8-K Entered a material agreement; Unregistered sale of equity Sep 28, 2023 8-K Regulation FD disclosure; Other events Sep 26, 2023